VESGEN 2D: automated, user-interactive software for quantification and mapping of angiogenic and lymphangiogenic trees and networks
- PMID: 19248164
- PMCID: PMC2880175
- DOI: 10.1002/ar.20862
VESGEN 2D: automated, user-interactive software for quantification and mapping of angiogenic and lymphangiogenic trees and networks
Abstract
Quantification of microvascular remodeling as a meaningful discovery tool requires mapping and measurement of site-specific changes within vascular trees and networks. Vessel density and other critical vascular parameters are often modulated by molecular regulators as determined by local vascular architecture. For example, enlargement of vessel diameter by vascular endothelial growth factor (VEGF) is restricted to specific generations of vessel branching (Parsons-Wingerter et al., Microvascular Research72: 91, 2006). The averaging of vessel diameter over many successively smaller generations is therefore not particularly useful. The newly automated, user-interactive software VESsel GENeration Analysis (VESGEN) quantifies major vessel parameters within two-dimensional (2D) vascular trees, networks, and tree-network composites. This report reviews application of VESGEN 2D to angiogenic and lymphangiogenic tissues that includes the human and murine retina, embryonic coronary vessels, and avian chorioallantoic membrane. Software output includes colorized image maps with quantification of local vessel diameter, fractal dimension, tortuosity, and avascular spacing. The density of parameters such as vessel area, length, number, and branch point are quantified according to site-specific generational branching within vascular trees. The sole user input requirement is a binary (black/white) vascular image. Future applications of VESGEN will include analysis of 3D vascular architecture and bioinformatic dimensions such as blood flow and receptor localization. Branching analysis by VESGEN has demonstrated that numerous regulators including VEGF(165), basic fibroblast growth factor, transforming growth factor beta-1, angiostatin and the clinical steroid triamcinolone acetonide induce 'fingerprint' or 'signature' changes in vascular patterning that provide unique readouts of dominant molecular signaling.
(c) 2009 Wiley-Liss, Inc.
Figures
References
-
- Avakian A, Kalina RE, Sage EH, Rambhia AH, Elliott KE, Chuang EL, Clark JI, Hwang J-N, Parsons-Wingerter P. Fractal analysis of region-based vascular change in the normal and non-proliferative diabetic retina. Curr Eye Res. 2002;24:274–280. - PubMed
-
- Barbosky L, Lawrence DK, Karunamuni G, Wikenheiser JC, Doughman YQ, Visconti RP, Burch JB, Watanabe M. Apoptosis in the developing mouse heart. Dev Dyn. 2006;235:2592–2602. - PubMed
-
- Benjamin LE, Hemo I, Keshet E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development. 1998;125:1591–1598. - PubMed
-
- Folkman J. Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov. 2007;6:273–286. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA092440/CA/NCI NIH HHS/United States
- K12 HD 049091/HD/NICHD NIH HHS/United States
- EY 017528/EY/NEI NIH HHS/United States
- HL 083048,/HL/NHLBI NIH HHS/United States
- CA 92440/CA/NCI NIH HHS/United States
- EY 017529/EY/NEI NIH HHS/United States
- HL 65314/HL/NHLBI NIH HHS/United States
- HL 0775436/HL/NHLBI NIH HHS/United States
- ES 013507/ES/NIEHS NIH HHS/United States
- R21 ES013507/ES/NIEHS NIH HHS/United States
- R01 EY017529/EY/NEI NIH HHS/United States
- R01 EY017528/EY/NEI NIH HHS/United States
- R01 HL065314/HL/NHLBI NIH HHS/United States
- K12 HD049091/HD/NICHD NIH HHS/United States
- R01 HL083048/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
